Cargando…

Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance

BACKGROUND: Several tests are performed to obtain better accuracy when diagnosing American tegumentary leishmaniasis (ATL). It is believed that antigens released via secretion, excretion and metabolism are more specific than are antigens released by the lysis of Leishmania parasites. Such antigens a...

Descripción completa

Detalles Bibliográficos
Autores principales: Soares, Killarney Ataide, Ayala Urdapilleta, Ada Amália, dos Santos, Gilcilene Maria, Carneiro, Andréa Lisboa, Gomes, Ciro Martins, Roselino, Ana Maria, Ribeiro Sampaio, Raimunda Nonata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425357/
https://www.ncbi.nlm.nih.gov/pubmed/25985901
http://dx.doi.org/10.1016/j.bjid.2015.03.010
_version_ 1784778430825365504
author Soares, Killarney Ataide
Ayala Urdapilleta, Ada Amália
dos Santos, Gilcilene Maria
Carneiro, Andréa Lisboa
Gomes, Ciro Martins
Roselino, Ana Maria
Ribeiro Sampaio, Raimunda Nonata
author_facet Soares, Killarney Ataide
Ayala Urdapilleta, Ada Amália
dos Santos, Gilcilene Maria
Carneiro, Andréa Lisboa
Gomes, Ciro Martins
Roselino, Ana Maria
Ribeiro Sampaio, Raimunda Nonata
author_sort Soares, Killarney Ataide
collection PubMed
description BACKGROUND: Several tests are performed to obtain better accuracy when diagnosing American tegumentary leishmaniasis (ATL). It is believed that antigens released via secretion, excretion and metabolism are more specific than are antigens released by the lysis of Leishmania parasites. Such antigens are known as exo-antigens (exo-Ag) and are formed from products released by cultured parasites in a way that is similar to that in which they cause infections in hosts. OBJECTIVE: We attempted to validate a Leishmania mexicana ELISA exo-Ag for ATL diagnosis in Midwestern Brazil. METHODS: A total of 281 patients were included in the study. We analysed pre-treatment blood from 98 ATL patients; out of those, 85.7% and 14.3% had cutaneous and mucosal forms, respectively. RESULTS: The exo-Ag accuracy was 83.99% (95% CI = 79.24–87.81) with a sensitivity value of 90.82% (95% CI = 83.46–95.09) and an overall specificity value of 80.33% (95% CI = 73.97–85.44). The positive predictive value and negative predictive value were 71.20% (95% CI = 62.72–78.41) and 94.23% (95% CI = 89.40–96.94), respectively. Among healthy controls, exo-Ag had a specificity of 91.25% (95% CI = 83.02–95.70); additionally, the test had specificity rates of 66.67% (95% CI = 46.71–82.03) in Chagas disease patients, 60.61% (95% CI = 43.68–75.32) in patients with rheumatic diseases, 76.92% (95% CI = 49.74–91.82) in pemphigus foliaceus patients, 87.50% (95% CI = 52.91–97.76) in leprosy patients, 87.50% (95% CI = 63.98–96.50) in VRDL-positive patients, and 77.78 (95% CI = 45.26–93.68) in deep mycosis patients. CONCLUSION: Based on the indicators of validity, we conclude that the results obtained in this study enable the recommendation of the exo-Ag ELISA for ATL diagnosis once it presented a reasonable accuracy compared to classical methods. Cost evaluations are necessary to completely define the role of this technique in large scale.
format Online
Article
Text
id pubmed-9425357
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94253572022-08-31 Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance Soares, Killarney Ataide Ayala Urdapilleta, Ada Amália dos Santos, Gilcilene Maria Carneiro, Andréa Lisboa Gomes, Ciro Martins Roselino, Ana Maria Ribeiro Sampaio, Raimunda Nonata Braz J Infect Dis Original Article BACKGROUND: Several tests are performed to obtain better accuracy when diagnosing American tegumentary leishmaniasis (ATL). It is believed that antigens released via secretion, excretion and metabolism are more specific than are antigens released by the lysis of Leishmania parasites. Such antigens are known as exo-antigens (exo-Ag) and are formed from products released by cultured parasites in a way that is similar to that in which they cause infections in hosts. OBJECTIVE: We attempted to validate a Leishmania mexicana ELISA exo-Ag for ATL diagnosis in Midwestern Brazil. METHODS: A total of 281 patients were included in the study. We analysed pre-treatment blood from 98 ATL patients; out of those, 85.7% and 14.3% had cutaneous and mucosal forms, respectively. RESULTS: The exo-Ag accuracy was 83.99% (95% CI = 79.24–87.81) with a sensitivity value of 90.82% (95% CI = 83.46–95.09) and an overall specificity value of 80.33% (95% CI = 73.97–85.44). The positive predictive value and negative predictive value were 71.20% (95% CI = 62.72–78.41) and 94.23% (95% CI = 89.40–96.94), respectively. Among healthy controls, exo-Ag had a specificity of 91.25% (95% CI = 83.02–95.70); additionally, the test had specificity rates of 66.67% (95% CI = 46.71–82.03) in Chagas disease patients, 60.61% (95% CI = 43.68–75.32) in patients with rheumatic diseases, 76.92% (95% CI = 49.74–91.82) in pemphigus foliaceus patients, 87.50% (95% CI = 52.91–97.76) in leprosy patients, 87.50% (95% CI = 63.98–96.50) in VRDL-positive patients, and 77.78 (95% CI = 45.26–93.68) in deep mycosis patients. CONCLUSION: Based on the indicators of validity, we conclude that the results obtained in this study enable the recommendation of the exo-Ag ELISA for ATL diagnosis once it presented a reasonable accuracy compared to classical methods. Cost evaluations are necessary to completely define the role of this technique in large scale. Elsevier 2015-05-15 /pmc/articles/PMC9425357/ /pubmed/25985901 http://dx.doi.org/10.1016/j.bjid.2015.03.010 Text en © 2015 Elsevier Editora Ltda. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Soares, Killarney Ataide
Ayala Urdapilleta, Ada Amália
dos Santos, Gilcilene Maria
Carneiro, Andréa Lisboa
Gomes, Ciro Martins
Roselino, Ana Maria
Ribeiro Sampaio, Raimunda Nonata
Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance
title Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance
title_full Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance
title_fullStr Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance
title_full_unstemmed Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance
title_short Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance
title_sort field validation of a leishmania (leishmania) mexicana exo-antigens elisa for diagnosing tegumentary leishmaniasis in regions of leishmania (viannia) predominance
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425357/
https://www.ncbi.nlm.nih.gov/pubmed/25985901
http://dx.doi.org/10.1016/j.bjid.2015.03.010
work_keys_str_mv AT soareskillarneyataide fieldvalidationofaleishmanialeishmaniamexicanaexoantigenselisafordiagnosingtegumentaryleishmaniasisinregionsofleishmaniavianniapredominance
AT ayalaurdapilletaadaamalia fieldvalidationofaleishmanialeishmaniamexicanaexoantigenselisafordiagnosingtegumentaryleishmaniasisinregionsofleishmaniavianniapredominance
AT dossantosgilcilenemaria fieldvalidationofaleishmanialeishmaniamexicanaexoantigenselisafordiagnosingtegumentaryleishmaniasisinregionsofleishmaniavianniapredominance
AT carneiroandrealisboa fieldvalidationofaleishmanialeishmaniamexicanaexoantigenselisafordiagnosingtegumentaryleishmaniasisinregionsofleishmaniavianniapredominance
AT gomesciromartins fieldvalidationofaleishmanialeishmaniamexicanaexoantigenselisafordiagnosingtegumentaryleishmaniasisinregionsofleishmaniavianniapredominance
AT roselinoanamaria fieldvalidationofaleishmanialeishmaniamexicanaexoantigenselisafordiagnosingtegumentaryleishmaniasisinregionsofleishmaniavianniapredominance
AT ribeirosampaioraimundanonata fieldvalidationofaleishmanialeishmaniamexicanaexoantigenselisafordiagnosingtegumentaryleishmaniasisinregionsofleishmaniavianniapredominance